1. Home
  2. ADXN vs SPGC Comparison

ADXN vs SPGC Comparison

Compare ADXN & SPGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • SPGC
  • Stock Information
  • Founded
  • ADXN 2002
  • SPGC 2018
  • Country
  • ADXN Switzerland
  • SPGC United States
  • Employees
  • ADXN N/A
  • SPGC N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • SPGC
  • Sector
  • ADXN Health Care
  • SPGC
  • Exchange
  • ADXN Nasdaq
  • SPGC Nasdaq
  • Market Cap
  • ADXN 8.9M
  • SPGC 7.4M
  • IPO Year
  • ADXN N/A
  • SPGC 2023
  • Fundamental
  • Price
  • ADXN $8.40
  • SPGC $0.50
  • Analyst Decision
  • ADXN
  • SPGC
  • Analyst Count
  • ADXN 0
  • SPGC 0
  • Target Price
  • ADXN N/A
  • SPGC N/A
  • AVG Volume (30 Days)
  • ADXN 3.0K
  • SPGC 89.8K
  • Earning Date
  • ADXN 08-08-2024
  • SPGC 08-15-2024
  • Dividend Yield
  • ADXN N/A
  • SPGC N/A
  • EPS Growth
  • ADXN N/A
  • SPGC N/A
  • EPS
  • ADXN N/A
  • SPGC N/A
  • Revenue
  • ADXN $1,568,105.00
  • SPGC $609,000.00
  • Revenue This Year
  • ADXN N/A
  • SPGC $732.95
  • Revenue Next Year
  • ADXN N/A
  • SPGC $142.00
  • P/E Ratio
  • ADXN N/A
  • SPGC N/A
  • Revenue Growth
  • ADXN N/A
  • SPGC 183.26
  • 52 Week Low
  • ADXN $5.00
  • SPGC $0.36
  • 52 Week High
  • ADXN $27.90
  • SPGC $30.00
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 47.54
  • SPGC 46.53
  • Support Level
  • ADXN $8.10
  • SPGC $0.42
  • Resistance Level
  • ADXN $8.67
  • SPGC $0.53
  • Average True Range (ATR)
  • ADXN 0.18
  • SPGC 0.06
  • MACD
  • ADXN 0.14
  • SPGC -0.00
  • Stochastic Oscillator
  • ADXN 72.16
  • SPGC 44.48

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About SPGC Sacks Parente Golf Inc.

Sacks Parente Golf Inc is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products. It designs, manufactures, and sells technology-forward, golf equipment, which is comprised of putting instruments, golf shafts, golf grips, and related product groups. It designs its golf products to fit golfers of all skill levels, amateur and professional. Its business segments currently include, golf putting instruments, golf shafts, and golf related products.

Share on Social Networks: